Coloplast Fair Value
CB
The fair market value of CBHD.DE stock is 125.07 EUR. Relative to the market price of 117.3 EUR Coloplast is undervalued by 6.6%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Coloplast Valuation
Current CBHD.DE share ticker price is 117.3 EUR.
The fair value level of 125.07 EUR can be considered as an effective entry point for long-term investors to start investing in CBHD.DE stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 7% lower its fair value
Current price is 10% higher its minimum value
Current price is 27% lower its maximum value
Market price:
CBHD.DE stock is undervalued
It means the current price may concern as a Moderate Risk Entry Point
Coloplast A/S Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
46.94
2
Median P/E over 5 years
39.47
3
Minimum P/E over 5 years
33.41
4
Earning per share (last 12 months)
23.59 DKK
Maximum value
1
x
4
=
148.75 EUR
Fair value
2
x
4
=
125.07 EUR
Minimum value
3
x
4
=
105.85 EUR
Coloplast A/S price metrics
3.28
Annual return (geometric mean)
27.16
Risk (standard deviation) of returns
β
0.5
Beta (volatility compared to market)